Free provider profile
TYLER KJORVESTAD, M.D.
NPI 1730541426
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2021-08-12.
3901 RAINBOW BLVD, KANSAS CITY, KS, 66160
913-588-1300
2 practice locations listed
Enumerated 2016-03-22
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 practice locations listed — multi-site footprint.
- — 5 taxonomies listed — broader service mix.
- — Record last updated 5 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
2,843
Medicare patients
318
Part D drug cost
$886,016
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 588 | $643,071 |
| Wellbutrin Xl (Bupropion Hcl) | 11 | $64,264 |
| Rexulti (Brexpiprazole) | 11 | $27,103 |
| Prozac (Fluoxetine Hcl) | 13 | $11,112 |
| Vyvanse (Lisdexamfetamine Dimesylate) | 17 | $6,488 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | 92 | $4,214 |
| Bupropion Xl (Bupropion Hcl) | 107 | $4,109 |
| Mirtazapine (Mirtazapine) | 156 | $3,199 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024237 sessions · 16 patients · $6,390
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.